Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
Abstract Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mof...
Guardado en:
Autores principales: | Snigdha Nutalapati, Garima Gupta, Gerhard C. Hildebrandt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1437eade9ac94ff394c89f134275467c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study
por: Farhad Handjani, et al.
Publicado: (2017) -
Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease
por: ZHANG,TONG, et al.
Publicado: (2009) -
Atrofia vellositaria duodenal inducida por micofenolato mofetil: Caso clínico
por: TAPIA E,OSCAR, et al.
Publicado: (2010) -
Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
por: Iqbal A, et al.
Publicado: (2020) -
Estudio de biodisponibilidad relativa entre dos formulaciones orales de micofenolato mofetilo en voluntarios sanos
por: Saavedra S,Iván, et al.
Publicado: (2011)